Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript November 4, 2024
Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9.
Operator: Thank you for standing by and welcome to Krystal Biotech’s Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today’s conference is being recorded. I would now like to hand the conference over to your host, Stéphane Paquette, Vice President of Corporate Development....
